…
In 2010, an international group of scientists published the first draft of the Neanderthal genome. And three years later, another large group of coauthors published a high-coverage, complete Neanderthal genome.
…
Beyond the remarkable advances concerning the sequencing of DNA, the 2010s saw the rapid establishment and development of a revolutionary genome editing strategy: CRISPR.
…
The 2010s were also momentous for personalized medicine and gene therapy. In 2017, the FDA approved the gene therapy Luxturna, which treats a single-gene disease that causes childhood blindness, making it the first such therapeutic to receive FDA approval.
…
I can’t help feeling that the 2020s have big things in store for several areas of life science. The excitement that has built around personalized medicine, CRISPR as a therapeutic tool, and AI presage wide applications for these still-young technologies. As they have been throughout the decade, bioethicists in the 2020s will need to remain ever vigilant, considering continuing developments such as the creation of human/animal chimeras, the genomic modification of human embryos, and the potential of more-accessible genome sequencing.
Read full, original post: What A Long, Strange Decade It’s Been